Resultados de la búsqueda

Kelly BB, Narula J, Fuster V. Recognizing global burden of cardiovascular disease and related chronic diseases. Mt Sinai J Med (2012) 79:632-40

Casasnovas JA, Alcalde V, Civeira F, Guallar E, Ibanez B, Jimenez-Borreguero J, Laclaustra M, Leon M, Ordovas JM, Pocovi M, Sanz G, Fuster V. Aragon workers' health study - design and cohort description. BMC Cardiovasc Disord (2012) 12:45
Link to the full text in Repisalud

Fernandez-Friera L, Garcia-Alvarez A, Guzman G, Garcia MJ. Coronary CT and the coronary calcium score, the future of ED risk stratification? Curr Cardiol Rev (2012) 8:86-97

Peñalvo JL, Céspedes J, Fuster V. Sesame street: changing cardiovascular risks for a lifetime. Semin Thorac Cardiovasc Surg. (2012) 24:238-40

Fayad ZA, Mani V, Woodward M, Kallend D, Abt M, Burgess T, Fuster V, Ballantyne CM, Stein EA, Tardif JC, Rudd JH, Farkouh ME, Tawakol A; for the dal-PLAQUE Investigators. Safety and efficacy of dalcetrapib on atherosclerotic disease using novel non-invasive multimodality imaging (dal-PLAQUE): a randomised clinical trial. Lancet (2011) 378:1547-59

Lobatto ME, Fuster V, Fayad ZA, Mulder WJ. Perspectives and opportunities for nanomedicine in the management of atherosclerosis. Nat Rev Drug Discov (2011) 10:835-52

Fuster V, Sweeny JM. Aspirin: a historical and contemporary therapeutic overview. Circulation (2011) 123:768-78

Fuster V, Kelly BB, Vedanthan R. Promoting global cardiovascular health: moving forward Circulation (2011) 123:1671-8

Kovacic JC, Moreno P, Hachinski V, Nabel EG, Fuster V Cellular senescence, vascular disease, and aging: part 1 of a 2-part review Circulation (2011) 123:1650-60

Kovacic JC, Moreno P, Nabel EG, Hachinski V, Fuster V. Cellular senescence, vascular disease, and aging: part 2 of a 2-part review: clinical vascular disease in the elderly. Circulation (2011) 123:1900-10